Chronic thromboembolic pulmonary hypertension after the first episode of pulmonary embolism? How often?
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F16%3A10323421" target="_blank" >RIV/00179906:_____/16:10323421 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11150/16:10323421
Výsledek na webu
<a href="http://biomed.papers.upol.cz/pdfs/bio/2016/01/16.pdf" target="_blank" >http://biomed.papers.upol.cz/pdfs/bio/2016/01/16.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2015.021" target="_blank" >10.5507/bp.2015.021</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Chronic thromboembolic pulmonary hypertension after the first episode of pulmonary embolism? How often?
Popis výsledku v původním jazyce
Background. Surviving pulmonary embolism (PE) brings a risk of thromboembolic disease chronicity. Chronic thromboembolic pulmonary hypertension (CTEPH) develops as a result of one or multiple pulmonary embolic events. It is an incapacitating long-term complication of thromboembolic disease with a negative impact on the patient's quality of life and prognosis. Contemporary pharmacological and especially surgical treatment possibilities offer hope for the patient's full recovery, but an early diagnosis is crucial for success. Methods. In a prospective study cohort of 97 consecutive patients with a proven diagnosis of PE as the first documented thromboembolic event we tried to estimate the incidence of CTEPH during a 2-year follow-up. Results. Four individuals from our study population developed CTEPH, which represents an incidence of 4.2%. Conclusion. Chronic thromboembolic pulmonary hypertension in pulmonary embolism survivors is a not uncommon complication deserving the attention of clinicians. Patients at risk of CTEPH can be identified for effective follow-up according to echocardiographic finding of elevated pulmonary artery systolic pressure and NT-proBNP levels at the time of hospital discharge.
Název v anglickém jazyce
Chronic thromboembolic pulmonary hypertension after the first episode of pulmonary embolism? How often?
Popis výsledku anglicky
Background. Surviving pulmonary embolism (PE) brings a risk of thromboembolic disease chronicity. Chronic thromboembolic pulmonary hypertension (CTEPH) develops as a result of one or multiple pulmonary embolic events. It is an incapacitating long-term complication of thromboembolic disease with a negative impact on the patient's quality of life and prognosis. Contemporary pharmacological and especially surgical treatment possibilities offer hope for the patient's full recovery, but an early diagnosis is crucial for success. Methods. In a prospective study cohort of 97 consecutive patients with a proven diagnosis of PE as the first documented thromboembolic event we tried to estimate the incidence of CTEPH during a 2-year follow-up. Results. Four individuals from our study population developed CTEPH, which represents an incidence of 4.2%. Conclusion. Chronic thromboembolic pulmonary hypertension in pulmonary embolism survivors is a not uncommon complication deserving the attention of clinicians. Patients at risk of CTEPH can be identified for effective follow-up according to echocardiographic finding of elevated pulmonary artery systolic pressure and NT-proBNP levels at the time of hospital discharge.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FA - Kardiovaskulární nemoci včetně kardiochirurgie
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NS9691" target="_blank" >NS9691: Morfologické změny plicního řečiště po plicní embolii</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Biomedical Papers
ISSN
1213-8118
e-ISSN
—
Svazek periodika
160
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
5
Strana od-do
125-129
Kód UT WoS článku
000373390800016
EID výsledku v databázi Scopus
2-s2.0-84962393949